Acelity Holdings, Inc. (NYSE:?) was reorganized on August 13, 2015 by 3 companies-Kinetic Concepts, Inc., LifeCell Corporation, and Systagenix Wound Management, Limited in San Antonio, Texas, USA, full-time With 5700 employees (12/31/2014), it is a leading global medical technology company dedicated to the development and commercialization of advanced wound care and regenerative medicine solutions.
Acelity is committed to medical smoking products that promote wound healing, thereby restoring people’s lives. Up to now, Acelity has provided innovative Acelity accelerated healing product portfolio and solutions in more than 75 countries, and has driven the industry in quality, safety and Improvement in customer experience.
Acelity operates in two parts:
- Advanced Wound Therapy Department -The focus is on the development and commercialization of innovative treatment solutions, including: negative pressure wound treatment, advanced dressings, negative pressure surgical treatment and skin regeneration. The business unit’s work spans wound care hospitals and communities, specializing in the research and development of advanced equipment and advanced wound dressings.
- Regenerative Medicine Department -focuses on the regeneration and reconstruction of cell matrix for general surgery to repair soft tissue defects, as well as the development and commercialization of autologous fat transplantation solutions.
Data for the 2014 fiscal year shows that 29% of Acelity’s revenue comes from non-US regions and countries, and the company’s products are exported to 75 countries. Therefore, the company can be regarded as a global multinational company. The company has approximately 1,800 employees worldwide. Marketing staff, 1,000 of them are engaged in sales activities in major hospitals and medical sponsors in the United States.
Acelity Holdings, Inc. has successfully established strong cooperative relationships with many companies, institutions and government units around the world, including hospitals, emergency departments, group purchasing organizations, individuals (clinics, etc.), and other important clinical companies and Clinical education institutions.
Acelity Holdings History:
- Acelity was originally Kinetic Concepts Inc. (KCI), a medical technology company founded in 1976 by Dr. Jim Leininger, an emergency room physician in San Antonio, Texas. Over time, the company has developed or acquired a series of special beds for treatment, and introduced special beds for patients with acute lung disease complications.
- In the early 1990s, KCI subdivided its business into four divisions: KCI New Technologies, Inc. (formed by Nutech in 1992 to focus on low-cost technology), KCI Home Care (organized in 1995 to focus on home medical equipment Suppliers selling wholesale), KCI Therapeutic Services, Inc. (renting KCTS special beds to patients or hospitals) and KCI International (KCII-established in 1991, focusing on providing KCI services and products to foreign countries, including Western Europe, Scandinavia Navia and most of Australia).
- In 1990, KCI purchased Medirec with US$26 million in cash and US$10 million in KCI stock, forming KCI’s Medical Services Division. KCI later sold KCI medical services for $65.3 million in cash and $18.8 million in promissory notes in September 1994.
- In 1991, KCI acquired Medicus International, a competitor of the British professional bed business. The transaction brought KCI products to 10 countries and established a subsidiary of KCI International.
- In 1996, KCI acquired Astec Medical Ltd. headquartered in the United Kingdom. This acquisition added four new products to KCI International’s product line and enabled KCI to expand its share of the British community market.
- In 1997, KCI acquired Ethos Medical Group. Later that year, Equitron Manufacturing was acquired, adding weight loss products to KCI’s family of home care products.
- In 1998, KCI’s New Technologies (NuTech) merged with KCI Therapeutic Services to form KCI USA. The merger unites the sales and marketing operations of the two departments.
- In 2008, KCI acquired LifeCell, a company specializing in regenerative medicine, for US$1.7 billion.
- In October 2013, KCI acquired Systagenix Wound Management for US$485 million, which was originally the professional wound care business of Johnson & Johnson .
- In September 2014, KCI’s parent company announced that KCI, LifeCell and Systagenix will operate under a global medical technology brand called Acelity. In the same year, Acelity obtained global exclusive rights from GID Group, Inc. to develop, produce and commercialize the REVOLVE system, which is a fat processing technology used in reconstruction and cosmetic surgery to promote mass autologous fat transplantation. Since 2013, LifeCell has owned the exclusive right to distribute the REVOLVE system in the United States and Canada.
- In 2015, Acelity acquired the SNAP business from Spiracur, Inc.
- On December 21, 2016, the pharmaceutical company Allergan announced the acquisition of LifeCell Corp. for US$2.9 billion. The transaction was completed on February 1 of the following year.
- In 2016, VAC Therapy treated more than 1,000 wounds.
- In April 2017, Acelity announced that R. Andrew Eckert will succeed Joseph Woody as CEO and President.
Acelity Holdings investment:
In August 2015, Acelity filed with the US Securities and Exchange Commission the registration statement of the proposed initial public offering (IPO) related to Form S-1. On December 7, 2016, the company withdrew its IPO registration statement with the US Securities and Exchange Commission.
Company website: acelity.com